The rate of colorectal cancer screenings more than doubled when patients were given a choice between which type of screening they wanted-;a take-home kit or colonoscopy-;compared to those who were only offered the colonoscopy, according to new research led by the Perelman School of Medicine at the University of Pennsylvania.